Using a Label Free Quantitative Proteomics Approach to Identify Changes in Protein Abundance in Multidrug-Resistant Mycobacterium tuberculosis
- PMID: 25805910
- PMCID: PMC4363256
- DOI: 10.1007/s12088-015-0511-2
Using a Label Free Quantitative Proteomics Approach to Identify Changes in Protein Abundance in Multidrug-Resistant Mycobacterium tuberculosis
Abstract
Reports in recent years indicate that the increasing emergence of resistance to drugs be using to TB treatment. The resistance to them severely affects to options for effective treatment. The emergence of multidrug-resistant tuberculosis has increased interest in understanding the mechanism of drug resistance in M. tuberculosis and the development of new therapeutics, diagnostics and vaccines. In this study, a label-free quantitative proteomics approach has been used to analyze proteome of multidrug-resistant and susceptible clinical isolates of M. tuberculosis and identify differences in protein abundance between the two groups. With this approach, we were able to identify a total of 1,583 proteins. The majority of identified proteins have predicted roles in lipid metabolism, intermediary metabolism, cell wall and cell processes. Comparative analysis revealed that 68 proteins identified by at least two peptides showed significant differences of at least twofolds in relative abundance between two groups. In all protein differences, the increase of some considering proteins such as NADH dehydrogenase, probable aldehyde dehydrogenase, cyclopropane mycolic acid synthase 3, probable arabinosyltransferase A, putative lipoprotein, uncharacterized oxidoreductase and six membrane proteins in resistant isolates might be involved in the drug resistance and to be potential diagnostic protein targets. The decrease in abundance of proteins related to secretion system and immunogenicity (ESAT-6-like proteins, ESX-1 secretion system associated proteins, O-antigen export system and MPT63) in the multidrug-resistant strains can be a defensive mechanism undertaken by the resistant cell.
Keywords: Label-free quantitation; Liquid chromatography mass spectrometry; Multidrug-resistance; Mycobacterium tuberculosis; Tuberculosis (TB).
Figures


Similar articles
-
T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates.Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S132-S133. doi: 10.1016/j.ijmyco.2016.10.009. Epub 2016 Oct 27. Int J Mycobacteriol. 2016. PMID: 28043507
-
Secretome profile analysis of multidrug-resistant, monodrug-resistant and drug-susceptible Mycobacterium tuberculosis.Arch Microbiol. 2018 Mar;200(2):299-309. doi: 10.1007/s00203-017-1448-0. Epub 2017 Nov 8. Arch Microbiol. 2018. PMID: 29119205
-
Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.PLoS One. 2015 Oct 5;10(10):e0139414. doi: 10.1371/journal.pone.0139414. eCollection 2015. PLoS One. 2015. PMID: 26436944 Free PMC article.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Current status and future trends in the diagnosis and treatment of drug-susceptible and multidrug-resistant tuberculosis.J Infect Public Health. 2014 Mar-Apr;7(2):75-91. doi: 10.1016/j.jiph.2013.09.001. Epub 2013 Nov 9. J Infect Public Health. 2014. PMID: 24216518 Review.
Cited by
-
Transcriptional Response of Mycobacterium tuberculosis to Cigarette Smoke Condensate.Front Microbiol. 2021 Oct 15;12:744800. doi: 10.3389/fmicb.2021.744800. eCollection 2021. Front Microbiol. 2021. PMID: 34721344 Free PMC article.
-
Genomic characteristics of Mycobacterium tuberculosis isolates of cutaneous tuberculosis.Front Microbiol. 2023 May 17;14:1165916. doi: 10.3389/fmicb.2023.1165916. eCollection 2023. Front Microbiol. 2023. PMID: 37266022 Free PMC article.
-
The ATP-Binding Cassette (ABC) Transport Systems in Mycobacterium tuberculosis: Structure, Function, and Possible Targets for Therapeutics.Biology (Basel). 2020 Dec 4;9(12):443. doi: 10.3390/biology9120443. Biology (Basel). 2020. PMID: 33291531 Free PMC article. Review.
-
Label-Free Comparative Proteomics of Differentially Expressed Mycobacterium tuberculosis Protein in Rifampicin-Related Drug-Resistant Strains.Pathogens. 2021 May 15;10(5):607. doi: 10.3390/pathogens10050607. Pathogens. 2021. PMID: 34063426 Free PMC article.
-
Signatures of Selection at Drug Resistance Loci in Mycobacterium tuberculosis.mSystems. 2018 Jan 30;3(1):e00108-17. doi: 10.1128/mSystems.00108-17. eCollection 2018 Jan-Feb. mSystems. 2018. PMID: 29404424 Free PMC article.
References
-
- WHO (2014) Tuberculosis. http://www.who.int/mediacentre/factsheets/fs104/en/
-
- WHO (2013) Multidrug-resistant tuberculosis (MDR-TB). http://www.who.int/tb/challenges/mdr/en/
-
- Taniguchi H, Aramaki H, Nikaido Y, Mizuguchi Y, Nakamura M, Koga T, Yoshida S (1996) Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett 144:103–108. doi:10.1016/0378-1097(96)00346-1 - PubMed
-
- Khadka JB, Rai SK, Shrestha S, Maharjan B, Bhatta DR, Ghimire P. Study of rifampicin and isoniazid resistance mutation genes of M. tuberculosis isolates in Nepal. Nepal Med Coll J. 2011;13:147–151. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources